Time-resolved contrast-enhanced magnetic resonance angiography of the hand with parallel imaging and view sharing: initial experience

We sought to compare a three-dimensional, contrast-enhanced, magnetic resonance angiogram (3D CE MRA) sequence combining parallel-imaging (generalised autocalibrating partially parallel acquisitions (GRAPPA)) with a time-resolved echo-shared angiographic technique (TREAT) in an intraindividual comparison to a standard 3D MRA sequence. Four healthy volunteers (27-32 years), and 11 patients (11-82 years) with vascular pathologies of the hand were examined on a 1.5-Tesla (T) MR system (Magnetom Avanto, Siemens, Erlangen, Germany) using two multichannel receiver coils. Following automatic injection (flow rate 2.5 cc/s) of 0.1 mmol/kg gadoterate (Dotarem, Guerbet, Roissy, France), 32 consecutive 3D data sets were collected with the TREAT sequence (TR/TE: 4.02/1.31 ms, FA: 10 , GRAPPA acceleration factor: R=2, TREAT factor: 5, voxel size: 1.0 x 0.7 x 1.3 mm3) and a T1-wighted 3D gradient-echo sequence (TR/TE: 5.3/1.57 ms, FA: 30 , GRAPPA acceleration factor: 2, voxel size: 0.71 x 0.71 x 0.71 mm3,). MR data sets were evaluated and compared for image quality and visualisation of vascular details. In the volunteer group, all MR imaging was successful while technical problems prevented acquisition of the standard protocol in two patients. For the corresponding segments, the number of visible segments was equal on both sequences. Overall image quality was significantly better on the standard protocol than on the TREAT protocol. TREAT MRA provided functional information in lesions with rapid blood flow, e.g. detection of feeding and draining vessels in an haemangioma. TREAT-MRA is a robust technique that combines morphological and functional information of the hand vasculature and deals with the very special physiological demands of vascular lesions, such as quick arteriovenous transit time. (orig.)